Skip to main content
21 November 2024
Last updated:
Monday 18 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Stock Market Performance
Stock market performance
Europe's biotech sector enjoys better Q3
Read more
Europe's capital markets continue to struggle
Read more
Provincialism holds back Europe's biotech sector
Read more
Long overdue, the EU capital markets plan is revived
Read more
Precision medicine is theme in quiet Q3 share market
Read more
Q2 stocks: Trial results, regulatory nods help European shares
Read more
Stock values decline and companies restructure
Read more
Q4 2022 Stock Comment
Read more
Biotech companies advised to conserve cash
Read more
Stocks plummet in Q2 but biotech keeps innovating
Read more
Pagination
Page 1
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form